Verici Dx CEO discusses the release of today's key clinical data wrt its new kidney transplant test.

-->

3rd Jul '23 by Paul Hill

3 comments 404 reads

Disclosure: I was paid by Vox Markets to interview the company.

Unlock with Email

Unlock with Google

Already have an account?
Login here

About the Author

Paul Hill

Premium Member

3 comments

stanley1

4th Jul '23

Hi Paul, thanks for the Q&A on VOX very interesting, bought a few more.

Any chance you could have a chat with Saietta to find out what the problem is there

stanley1

4th Jul '23

Sorry, meant Verici too many V's getting a bit daft in my old age

Paul Hill

8th Jul '23

Yes will do Stanley1, hopefully soon. Watch this space.

Unlock the metrics for all these stocks and more...

Take a free trial

Facebook Twitter Youtube Instagram RSS

This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.

Unlock the metrics for all these stocks and more...

Take a free trial

Verici Dx CEO discusses the release of today's key clinical data wrt its new kidney transplant test.

Unlock the rest of this article with a 14 day trial

About the Author

Paul Hill

3 comments

Unlock the metrics for all these stocks and more...

Unlock the metrics for all these stocks and more...